1 in 11 people in the world suffer from diabetes. Although diabetes can be treated today, it is a disease that cannot be cured.
Adocia has filed a patent that could revolutionize the future of patients living with diabetes: a hydrogel matrix that allows the transplant of insulin-producing pancreatic cells. Thanks to the hydrogel matrix, the dream of many patients could come true: to have access to cell therapy and regain autonomy by abandoning daily insulin injections.
Discover Adocia’s Video about cell therapy (In French)